Trials / Unknown
UnknownNCT04632823
"The Effect of Comprehensive Non-pharmacological Treatment on Metabolic Disorders in Type 2 Diabetic Patients"
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Astana Medical University · Academic / Other
- Sex
- All
- Age
- 45 Years – 59 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the effectiveness of comprehensive non-pharmacological treatment on metabolic disorders in type 2 diabetic patients
Detailed description
Patients in the intervention group will participate in a comprehensive non-pharmacological treatment of type 2 diabetes, the main components are: * changing the meal plan (individual and group counseling, assistance in developing menus and determining the calorie intake, keeping a food diary) * individually dosed physical exercises using specific exercise program; * comprehensive training (course of interactive lessons, self-control training). The program included group sessions with a team of specialists: nutritionist, endocrinologist, physical therapy doctor and included 3 sessions per week for 24 weeks. Each visit included teaching patients in a group format and in an interactive form (classes with specialists alternated), performing physical exercises using the specific exercise program under the supervision of a physiotherapy physician, evaluating medical indicators, and a self-control diary. Patients in the control group will not participate in group sessions, but they had the opportunity to receive non-pharmacological care provided in the framework of free outpatient care. Their indicators will be recorded during a routine visit to the doctor at the baseline, after 12 and 24 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Comprehensive Non-pharmacological Treatment Program | dietary supplement, specific type of exercise, self-management education |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2021-02-01
- Completion
- 2021-06-01
- First posted
- 2020-11-17
- Last updated
- 2020-11-17
Locations
4 sites across 2 countries: Kazakhstan, Russia
Source: ClinicalTrials.gov record NCT04632823. Inclusion in this directory is not an endorsement.